Ultragenyx Pharmaceutical Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: RARE
Share price (6/3/26): $22.41
Market cap (6/3/26): $2.207 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 10-K 35 pages Asset Purchase Agreement by and Between Novartis Pharma AG, Ultragenyx Pharmaceutical Inc., and Ultragenyx International Ux003 Ltd. December 14, 2017

from 8-K 80 pages Agreement and Plan of Merger by and Among: Dimension Therapeutics, Inc., a Delaware Corporation; Ultragenyx Pharmaceutical Inc., a Delaware Corporation; and Mystic River Merger Sub Inc., a Delaware Corporation Dated as of October 2, 2017

from SC TO-C 80 pages Agreement and Plan of Merger by and Among: Dimension Therapeutics, Inc., a Delaware Corporation; Ultragenyx Pharmaceutical Inc., a Delaware Corporation; and Mystic River Merger Sub Inc., a Delaware Corporation Dated as of October 2, 2017